Class Action

DayQuil, NyQuil, and Theraflu

Class Action

DayQuil, NyQuil, and Theraflu


Case Name (Date)

Juneau et al. v. The Procter & Gamble Co. and GSK Consumer Healthcare, Inc.
23-cv-5273, E.D. La.
(Sept. 2023)


Product/Service

DayQuil Severe, NyQuil Severe Cold & Flu, Theraflu Multi-Symptom Severe Cold/Severe Cold Cough, and other cold and flu medicines


Allegations

Falsely marketing that medicines treat nasal congestion when the active ingredient (phenylephrine) is not an effective decongestant


Status

Pending



Class-Action Tracker


The Latest

Filters

Gillette Engaged in Deceptive Made in USA Marketing

Press Release

Gillette Engaged in Deceptive Made in USA Marketing

Ad Watchdog TINA.org Files FTC Complaint MADISON, CONN. January 23, 2018 – Despite a national advertising campaign showcasing patriotic imagery, highlighting its Boston headquarters, and heavily promoting its “Made in…


Show More